Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Scientific Reports|March 4, 2016
Deciphering the Potential Pharmaceutical Mechanism of Chinese Traditional Medicine (Gui-Zhi-Shao-Yao-Zhi-Mu) on Rheumatoid ArthritisLin Huang, Qi Lv, Duoli Xie, et al.Oncotarget|April 29, 2017
Personalizing Chinese medicine by integrating molecular features of diseases and herb ingredient information: application to acute myeloid leukemiaLin Huang, Haichang Li, Duoli Xie, et al.European Journal of Medicinal Chemistry|November 6, 2024
Development of hybrid aptamers-engineered PROTACs for degrading VEGF165 in both tumor- and vascular endothelial cellsZiting Feng, Duoli Xie, Fang Qiu, et al.Frontiers in Immunology|January 10, 2022
Toward Overcoming Treatment Failure in Rheumatoid ArthritisZhuqian Wang, Jie Huang, Duoli Xie, et al.Frontiers in Oncology|March 21, 2022
Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma TreatmentDuoli Xie, Zhuqian Wang, Jie Li, et al.Nucleic Acids Research|November 7, 2017
TCMID 2.0: a comprehensive resource for TCMLin Huang, Duoli Xie, Yiran Yu, et al.Scientific Reports|October 19, 2017
Dissecting the Underlying Pharmaceutical Mechanism of Chinese Traditional Medicine Yun-Pi-Yi-Shen-Tong-Du-Tang Acting on Ankylosing Spondylitis through Systems Biology ApproachesDuoli Xie, Lin Huang, Guanghui Zhao, et al.Scientific Reports|January 25, 2019
Deciphering the Potential Pharmaceutical Mechanism of GUI-ZHI-FU-LING-WAN on Systemic Sclerosis based on Systems Biology ApproachesQiao Wang, Guoshan Shi, Yun Zhang, et al.Journal of Orthopaedic Translation|October 1, 2025
An aptamer specifically targeting mCRP ameliorates experimental arthritisZhuqian Wang, Duoli Xie, Peixi Zhu, et al.Journal of Medicinal Chemistry|February 9, 2026
Design, Synthesis, and Evaluation of Nucleolin-Bridged, MDM2-Recruiting IRAK4 Degraders for the Treatment of Autoimmune DiseasesZiting Feng, Xiaoxuan Zhang, Yi Ding, et al.Pageof 3